Banque Cantonale Vaudoise Biomea Fusion, Inc. Transaction History
Banque Cantonale Vaudoise
- $2.55 Billion
- Q1 2024
A detailed history of Banque Cantonale Vaudoise transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Banque Cantonale Vaudoise holds 20 shares of BMEA stock, worth $90. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20Holding current value
$90% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BMEA
# of Institutions
121Shares Held
25.7MCall Options Held
2.56MPut Options Held
879K-
State Street Corp Boston, MA4.49MShares$20.2 Million0.0% of portfolio
-
Cormorant Asset Management, LP Boston, MA3.57MShares$16.1 Million3.07% of portfolio
-
Laurion Capital Management LP New York, NY2.72MShares$12.2 Million0.36% of portfolio
-
Baker Bros. Advisors LP New York, NY2.11MShares$9.49 Million0.4% of portfolio
-
Black Rock Inc. New York, NY1.97MShares$8.88 Million0.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $132M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...